Cargando…
The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms
Major depressive disorder (MDD) is a heterogeneous psychiatric disease characterized by persistent low mood, diminished interests, and impaired cognitive and social functions. The multifactorial etiology of MDD is still largely unknown because of the complex genetic and environmental interactions in...
Autores principales: | Dattilo, Vincenzo, Amato, Rosario, Perrotti, Nicola, Gennarelli, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419621/ https://www.ncbi.nlm.nih.gov/pubmed/32849818 http://dx.doi.org/10.3389/fgene.2020.00826 |
Ejemplares similares
-
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
por: Guerriero, Ilaria, et al.
Publicado: (2020) -
RANBP1, a member of the nuclear-cytoplasmic trafficking-regulator complex, is the terminal-striking point of the SGK1-dependent Th17(+) pathological differentiation
por: Brescia, Carolina, et al.
Publicado: (2023) -
In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity
por: D'Antona, Lucia, et al.
Publicado: (2019) -
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation
por: Dattilo, Vincenzo, et al.
Publicado: (2017) -
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy
por: Talarico, Cristina, et al.
Publicado: (2015)